Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation.

In view of these findings, we propose that decreased amounts of NLGN4X are indicative of a metastatic melanoma phenotype and that loss of NLGN4X provides a novel mechanism for HIF induction.